FilingReader Intelligence
Pientzehuang Pharmaceutical invests 200m yuan in healthcare fund
August 6, 2025 at 11:49 AM UTC•By FilingReader AI
Zhangzhou Pientzehuang Pharmaceutical announced its subsidiary will invest 200 million yuan as a limited partner in the Gaoxin Runxin Greater Healthcare Industry Investment Partnership.
The investment represents 20% of the fund's 1 billion yuan target fundraising scale. The fund will focus on pharmaceuticals, medical devices, and related supply chains.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600436•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Zhangzhou Pientzehuang Pharmaceutical publishes news
Free account required • Unsubscribe anytime